Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Tuesday's Intraday Session

Author: Benzinga Insights | August 29, 2023 01:31pm

Gainers

  • Axcella Health (NASDAQ:AXLA) stock increased by 277.6% to $0.43 during Tuesday's regular session. The current volume of 263.9 million shares is 21075.6% of Axcella Health's average full-day volume over the last 100 days (last updated at 13:31 EST). The company's market cap stands at $31.3 million.
  • Tivic Health Systems (NASDAQ:TIVC) stock moved upwards by 63.4% to $3.17. Trading volume for Tivic Health Systems's stock is 23.4 million as of 13:31 EST. This is 5342.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $4.6 million.
  • Taysha Gene Therapies (NASDAQ:TSHA) shares moved upwards by 31.92% to $3.14. Taysha Gene Therapies's stock is trading at a volume of 11.0 million shares as of 13:31 EST. This is 281.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $586.7 million.
  • Akso Health Group (NASDAQ:AHG) shares rose 29.98% to $0.66. The current volume of 1.3 million shares is 1691.1% of Akso Health Group's average full-day volume over the last 100 days (last updated at 13:31 EST). The company's market cap stands at $15.1 million.
  • NeuroPace (NASDAQ:NPCE) shares moved upwards by 26.25% to $8.8. Trading volume for this security as of 13:31 EST is 214.5K, which is 481.2% of its average full-day volume over the last 100 days. The company's market cap stands at $227.5 million.
  • P3 Health Partners (NASDAQ:PIII) stock rose 24.82% to $1.76. Trading volume for this security as of 13:31 EST is 514.5K, which is 106.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $201.0 million.

Losers

  • Longeveron Inc. - Subscription Right (NASDAQ:LGVNR) shares declined by 19.7% to $0.02 during Tuesday's regular session. The current volume of 618.4K shares is 158.7% of Longeveron Inc. - Subscription Right's average full-day volume over the last 100 days (last updated at 13:31 EST).
  • T2 Biosystems (NASDAQ:TTOO) shares decreased by 16.57% to $0.28. The current volume of 62.8 million shares is 56.0% of T2 Biosystems's average full-day volume over the last 100 days (last updated at 13:31 EST). The company's market cap stands at $93.2 million.
  • Pulse Biosciences (NASDAQ:PLSE) shares declined by 15.32% to $4.81. Trading volume for Pulse Biosciences's stock is 1.0 million as of 13:31 EST. This is 630.9% of its average full-day volume over the last 100 days. The company's market cap stands at $264.0 million.
  • Capricor Therapeutics (NASDAQ:CAPR) shares declined by 14.27% to $6.73. As of 13:31 EST, this security is trading at a volume of 278.9K shares, making up 263.7% of its average full-day volume over the last 100 days. The company's market cap stands at $173.4 million.
  • Ontrak (NASDAQ:OTRKP) shares fell 11.06% to $0.45.
  • PHAXIAM Therapeutics (NASDAQ:PHXM) shares declined by 10.89% to $0.52. The market value of their outstanding shares is at $31.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: AHG AXLA CAPR LGVNR NPCE OTRKP PHXM PIII PLSE TIVC TSHA TTOO

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist